Cargando…
Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy
High doses of radiation can cause serious side effects and efficient radiosensitizers are urgently needed. To overcome this problem, we developed a biomimetic nanozyme system (CF) by coating pyrite (FeS(2)) into tumor-derived exosomes for enhanced low-dose radiotherapy (RT). CF system give FeS(2) wi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715603/ https://www.ncbi.nlm.nih.gov/pubmed/34963466 http://dx.doi.org/10.1186/s12951-021-01182-y |
_version_ | 1784624159586779136 |
---|---|
author | Huang, Chunyu Liu, Zeming Chen, Mingzhu Du, Liang Liu, Chunping Wang, Shuntao Zheng, Yongfa Liu, Wei |
author_facet | Huang, Chunyu Liu, Zeming Chen, Mingzhu Du, Liang Liu, Chunping Wang, Shuntao Zheng, Yongfa Liu, Wei |
author_sort | Huang, Chunyu |
collection | PubMed |
description | High doses of radiation can cause serious side effects and efficient radiosensitizers are urgently needed. To overcome this problem, we developed a biomimetic nanozyme system (CF) by coating pyrite (FeS(2)) into tumor-derived exosomes for enhanced low-dose radiotherapy (RT). CF system give FeS(2) with immune escape and homologous targeting abilities. After administration, CF with both glutathione oxidase (GSH-OXD) and peroxidase (POD) activities can significantly lower the content of GSH in tumor tissues and catalyze intracellular hydrogen peroxide (H(2)O(2)) to produce a large amount of ·OH for intracellular redox homeostasis disruption and mitochondria destruction, thus reducing RT resistance. Experiments in vivo and in vitro showed that combining CF with RT (2 Gy) can provide a substantial suppression of tumor proliferation. This is the first attempt to use exosomes bionic FeS(2) nanozyme for realizing low-dose RT, which broaden the prospects of nanozymes. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01182-y. |
format | Online Article Text |
id | pubmed-8715603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-87156032022-01-05 Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy Huang, Chunyu Liu, Zeming Chen, Mingzhu Du, Liang Liu, Chunping Wang, Shuntao Zheng, Yongfa Liu, Wei J Nanobiotechnology Research High doses of radiation can cause serious side effects and efficient radiosensitizers are urgently needed. To overcome this problem, we developed a biomimetic nanozyme system (CF) by coating pyrite (FeS(2)) into tumor-derived exosomes for enhanced low-dose radiotherapy (RT). CF system give FeS(2) with immune escape and homologous targeting abilities. After administration, CF with both glutathione oxidase (GSH-OXD) and peroxidase (POD) activities can significantly lower the content of GSH in tumor tissues and catalyze intracellular hydrogen peroxide (H(2)O(2)) to produce a large amount of ·OH for intracellular redox homeostasis disruption and mitochondria destruction, thus reducing RT resistance. Experiments in vivo and in vitro showed that combining CF with RT (2 Gy) can provide a substantial suppression of tumor proliferation. This is the first attempt to use exosomes bionic FeS(2) nanozyme for realizing low-dose RT, which broaden the prospects of nanozymes. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01182-y. BioMed Central 2021-12-28 /pmc/articles/PMC8715603/ /pubmed/34963466 http://dx.doi.org/10.1186/s12951-021-01182-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Huang, Chunyu Liu, Zeming Chen, Mingzhu Du, Liang Liu, Chunping Wang, Shuntao Zheng, Yongfa Liu, Wei Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title | Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title_full | Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title_fullStr | Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title_full_unstemmed | Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title_short | Tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
title_sort | tumor-derived biomimetic nanozyme with immune evasion ability for synergistically enhanced low dose radiotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715603/ https://www.ncbi.nlm.nih.gov/pubmed/34963466 http://dx.doi.org/10.1186/s12951-021-01182-y |
work_keys_str_mv | AT huangchunyu tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT liuzeming tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT chenmingzhu tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT duliang tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT liuchunping tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT wangshuntao tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT zhengyongfa tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy AT liuwei tumorderivedbiomimeticnanozymewithimmuneevasionabilityforsynergisticallyenhancedlowdoseradiotherapy |